Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ultralife (ULBI) EBIT Margin (2016 - 2025)

Ultralife has reported EBIT Margin over the past 16 years, most recently at 21.88% for Q4 2025.

  • Quarterly results put EBIT Margin at 21.88% for Q4 2025, down 2524.0% from a year ago — trailing twelve months through Dec 2025 was 3.09% (down 915.0% YoY), and the annual figure for FY2025 was 3.09%, down 915.0%.
  • EBIT Margin for Q4 2025 was 21.88% at Ultralife, down from 2.19% in the prior quarter.
  • Over the last five years, EBIT Margin for ULBI hit a ceiling of 9.69% in Q1 2024 and a floor of 21.88% in Q4 2025.
  • Median EBIT Margin over the past 5 years was 3.36% (2024), compared with a mean of 1.68%.
  • Biggest five-year swings in EBIT Margin: surged 961bps in 2024 and later plummeted -2524bps in 2025.
  • Ultralife's EBIT Margin stood at 5.17% in 2021, then surged by 66bps to 1.76% in 2022, then skyrocketed by 565bps to 8.19% in 2023, then crashed by -59bps to 3.36% in 2024, then plummeted by -751bps to 21.88% in 2025.
  • The last three reported values for EBIT Margin were 21.88% (Q4 2025), 2.19% (Q3 2025), and 4.65% (Q2 2025) per Business Quant data.